Uruguay’s Pharmacy Cannabis Sales Jump as Store Expansion Starts to Convert Into Volume

March sales reached 525 kilograms when Uruguay finally had enough stores to test demand

Uruguay’s legal adult-use cannabis market sold 525 kilograms through pharmacies in March 2026. A year earlier, the same month produced 348 kilograms. That is a 51 percent increase in the country’s main commercial retail channel.

The number matters because it arrives with a fresh official read on the market. On May 11, the Institute for the Regulation and Control of Cannabis, the state cannabis regulator known as IRCCA, published its first-four-month update for 2026. The report shows a system that is no longer just adding registered users on paper. It is moving more product through a broader store base.

By April 30, Uruguay had 60 pharmacies authorized to sell adult-use cannabis. The report also counted 88,955 people registered to buy through pharmacies and 120,083 registered users across the three legal adult-use routes. Those routes are pharmacy purchase, cannabis clubs, and home cultivation. In practice, that means the state is tracking not only how many people are allowed into the legal market, but where they are actually getting supply.

The shift is important because Uruguay’s legal framework has long been judged on reach as much as on legality. The country legalized adult-use cannabis early, but the rollout moved cautiously. Store coverage was uneven, the network was small, and legal access often depended on where a person lived rather than whether the law allowed purchase. The latest report suggests that one of the market’s oldest bottlenecks, simple physical access to a legal point of sale, is starting to loosen.

That is why the March sales figure carries more weight than a single monthly spike would suggest. The market is not just larger in registrations. It is beginning to look more usable.

Why a 60-pharmacy network changes the shape of a regulated market

Uruguay’s adult-use system is unusually structured. It does not run on a broad retail free-for-all. A legal customer must use one of three state-recognized channels: buy from a participating pharmacy, join a cannabis club that collectively produces for members, or register to grow at home. Each route is legal, but each route solves a different practical problem.

Pharmacies matter because they are the only mass retail channel in that structure. Clubs require membership, organization, and waiting lists. Homegrow requires space, time, and willingness to cultivate. A pharmacy purchase is the closest thing Uruguay has to ordinary consumer access for non-medical cannabis. If that route remains thin, the legal market remains narrow even when the law itself is broad.

That helps explain why store growth is such a meaningful operating signal. Trade reporting around the IRCCA update said 20 pharmacies were added between January 2025 and April 2026, with expansion reaching places such as Rivera and Tacuarembó that had been less well served. For a conventional retail category, 20 extra outlets might sound modest. In Uruguay’s cannabis system, where the entire national network is counted in the dozens, it is a structural change.

The official numbers suggest those extra access points are translating into real purchase volume. More than 1.9 million grams were sold through pharmacies in the first four months of 2026, according to local reporting based on the IRCCA data. March alone accounted for 525,000 grams. That indicates the network is not simply spreading sales more thinly across more stores. It is bringing additional legal demand into the channel.

There is a second layer to the report that matters just as much. IRCCA recorded 34,122 active pharmacy purchasers in April. That is far below the 88,955 people registered for the pharmacy route. In other words, a large user base is enrolled, but only part of it buys in any given month.

That gap does not weaken the story. It sharpens it. Registration shows potential demand and legal eligibility. Monthly activity shows actual shopping behavior. Uruguay now appears to have both a large retail-registered population and rising product throughput, but it does not yet have universal monthly use of the legal retail channel. That is exactly what a market in transition looks like.

It also clarifies the role of compliance. The report noted 448 inspections in the first four months of the year. In a regulated consumer market, inspections are not a side note. They are the state’s way of keeping a tightly designed system credible enough to expand. Retail growth without enforcement would raise doubts about diversion, stock controls, and recordkeeping. Enforcement activity signals that the government is still treating adult-use cannabis as a supervised public system, not just another packaged product.

Pharmacies are taking more of the market even as clubs remain central and homegrow softens

The wider market picture is not just about stores. It is about which legal route is proving most durable as Uruguay’s system matures.

Pharmacies now hold the largest registered user base among the legal access routes, with 88,955 people signed up to buy there. Cannabis clubs remain substantial, with 585 clubs recorded in the first four months of 2026. Home cultivation remains part of the legal framework, but local reporting on the latest data points to a decline in active homegrow registrations to 10,330.

That combination matters because it shows the legal market settling into a hierarchy. The easiest scaled channel is retail. The organized community channel is clubs. The most individual and least scalable route is homegrow. For years, Uruguay’s three-track model was often described as a balance among equal options. The latest figures suggest the balance is becoming more practical and less theoretical. Retail and clubs are doing more of the work.

For pharmacies themselves, that is consequential. Many retailers have historically viewed cannabis participation as operationally sensitive. Security requirements, specialized handling, social stigma, and political scrutiny all raise the threshold for joining the system. A growing national network paired with higher monthly sales changes that calculation. It suggests the channel can generate repeat traffic and public-normalized use rather than occasional symbolic purchases.

For cultivators and licensed suppliers, the shift is equally important. A retail system with stronger volume can support more predictable production planning than a market dominated by home cultivation. Pharmacy demand is not fully stable yet, but it is measurable, audited, and geographically traceable. That gives the supply side a firmer demand signal than simple registration totals do.

For clubs, the message is more mixed. The latest numbers do not show displacement so much as coexistence. Clubs still represent a large and distinctly Uruguayan part of the legal market. They serve consumers who prefer a membership model, want access outside standard retail habits, or value a collective production structure. But the stronger pharmacy figures make one point clear: clubs are no longer carrying the burden of proving that the legal system can supply adults at scale.

The broader policy implication is that Uruguay may be getting closer to the practical goal behind legalization, which was not only to permit consumption but to channel it into monitored, legal supply. A legal market does not compete with illicit sellers by statute alone. It competes on availability, convenience, and habit. More stores in more places, selling more product to more registered buyers, is what that competition looks like in administrative terms.

Still, some caution is necessary. Only 38 percent of registered pharmacy users were active buyers in April, according to trade reporting based on the IRCCA figures. That means a majority of people registered for pharmacy access did not buy that month. Some may buy intermittently. Some may use clubs or other legal routes instead. Some may remain partly outside the regulated market. The report does not settle that question.

The real test now is not legalization but whether legal retail becomes routine

The most important change in Uruguay is not that cannabis is legal. That question was settled years ago. The live question is whether legal supply is becoming ordinary enough to displace workarounds, shortages of access, and reliance on non-retail channels where retail would otherwise be the natural choice.

The latest numbers suggest a system moving in that direction. A 51 percent year-over-year rise in March pharmacy sales is too large to dismiss as statistical noise. Sixty pharmacies is still a small network by the standards of mainstream retail, but it is materially larger than Uruguay had before. Nearly 89,000 pharmacy-registered buyers is a serious addressable consumer base in a country of Uruguay’s size. And the fact that the government is publishing detailed first-four-month updates signals that this is now a monitored market in operation, not an abstract policy experiment.

But the data also shows what remains unfinished. A registered buyer is not the same thing as an active monthly customer. A broader network is not yet full national convenience. Strong March volume is encouraging, but one strong month does not by itself prove stable purchasing patterns across the year. Clubs are still a major pillar. Homegrow has not disappeared. And the report, while useful, does not fully answer how much legal growth is coming from new users, channel switching, or substitution away from illicit sources.

That uncertainty should not obscure the main conclusion. Uruguay’s pharmacy channel is finally beginning to behave like market infrastructure. That is a more consequential development than the monthly sales headline on its own. Infrastructure changes habits. It changes operator incentives. It changes where supply is planned, where compliance is enforced, and where policy success or failure can be measured.

If the country can keep expanding coverage, maintain inspections, and turn a large registered base into more consistent monthly purchasing, the legal retail channel will start to do what legalization alone never could: make the regulated market the default. That is the threshold Uruguay now appears to be approaching.